USPTO trademark

SLTX

RegisteredUSPTOWord markClass 1Class 5

"SLTX" is a word mark owned by Sigilon Therapeutics, Inc., filed at the USPTO on November 16, 2018. It is registered and covers classes 1 and 5.

Get this data via the API

Data current as of March 18, 2024Official USPTO record

As filed with the USPTO

Status: Registered; Since November 17, 2020
Filed: November 16, 2018
Registered: November 17, 2020
Expires: Not recorded
Application no.: 88197578
Registration no.: 6201037
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 2 classes

Ownership

Who owns SLTX

The owner and representative on file with the office.

Owner

Sigilon Therapeutics, Inc.

Cambridge, United States

Representative

John R. Rudolph

Eli Lilly and Company

Goods and services

What the mark covers

The products and services SLTX is filed for, grouped by Nice class.

01Class 1 · Chemicals
Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use
05Class 5 · Pharmaceuticals
Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells

History

What has happened so far

Steps recorded by the USPTO, newest first.

November 17, 2025Courtesy reminder - sec. 8 (6-yr) e-mailed
March 18, 2024Teas change of correspondence received
March 18, 2024Attorney/dom.rep.revoked and/or appointed
March 18, 2024Teas revoke/app/change addr of atty/dom rep received
March 18, 2024Applicant/correspondence changes (non-responsive) entered
March 18, 2024Teas change of owner address received
November 17, 2020Registered-principal register
October 14, 2020Notice of acceptance of statement of use e-mailed
October 13, 2020Allowed principal register - sou accepted
October 7, 2020Statement of use processing complete

10 earlier steps on the official record.

FAQ

About SLTX

Who owns the trademark "SLTX"?

The USPTO trademark "SLTX" (application 88197578) is owned by Sigilon Therapeutics, Inc.

What is the status of "SLTX"?

Its status at the USPTO is: registered.

When was "SLTX" registered?

It was registered on November 17, 2020.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SLTX and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d29fb-9895-77a9-9e1d-80c64f800b61
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d29fb-9895-77a9-9e1d-80c64f800b61",
  "object": "trademark",
  "mark_text": "SLTX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88197578",
  "filing_date": "2018-11-16",
  "nice_classes": [
    1,
    5
  ],
  "owners": [
    {
      "name": "Sigilon Therapeutics, Inc.",
      "entity_id": null
    }
  ]
}